Caxton Associates LLP bought a new stake in Lemonade, Inc. (NYSE:LMND - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The fund bought 46,284 shares of the company's stock, valued at approximately $1,455,000. Caxton Associates LLP owned approximately 0.06% of Lemonade as of its most recent filing with the SEC.
Other institutional investors and hedge funds also recently made changes to their positions in the company. The Manufacturers Life Insurance Company boosted its stake in shares of Lemonade by 7.7% in the 4th quarter. The Manufacturers Life Insurance Company now owns 31,000 shares of the company's stock valued at $1,137,000 after purchasing an additional 2,209 shares in the last quarter. Nomura Holdings Inc. bought a new position in shares of Lemonade in the first quarter valued at about $416,000. Dynamic Technology Lab Private Ltd bought a new position in shares of Lemonade in the first quarter valued at about $638,000. GAMMA Investing LLC raised its holdings in shares of Lemonade by 35,901.8% in the first quarter. GAMMA Investing LLC now owns 19,801 shares of the company's stock valued at $630,000 after buying an additional 19,746 shares during the last quarter. Finally, Northern Trust Corp raised its holdings in shares of Lemonade by 23.7% in the fourth quarter. Northern Trust Corp now owns 562,502 shares of the company's stock valued at $20,633,000 after buying an additional 107,592 shares during the last quarter. Institutional investors and hedge funds own 80.30% of the company's stock.
Lemonade Stock Performance
NYSE:LMND traded up $2.12 on Friday, hitting $52.54. 2,188,830 shares of the stock were exchanged, compared to its average volume of 1,880,569. The stock has a market capitalization of $3.88 billion, a price-to-earnings ratio of -18.57 and a beta of 2.28. Lemonade, Inc. has a 52 week low of $15.27 and a 52 week high of $60.41. The company's 50-day moving average price is $47.55 and its 200 day moving average price is $38.67.
Lemonade (NYSE:LMND - Get Free Report) last announced its quarterly earnings data on Tuesday, August 5th. The company reported ($0.60) earnings per share for the quarter, topping the consensus estimate of ($0.81) by $0.21. The firm had revenue of $164.10 million during the quarter, compared to analysts' expectations of $160.88 million. Lemonade had a negative return on equity of 36.12% and a negative net margin of 33.96%.The company's quarterly revenue was up 34.5% compared to the same quarter last year. During the same period in the previous year, the business posted ($0.81) EPS. Lemonade has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities research analysts predict that Lemonade, Inc. will post -3.03 earnings per share for the current year.
Insider Activity
In other news, insider John Sheldon Peters sold 6,543 shares of the business's stock in a transaction dated Monday, June 23rd. The stock was sold at an average price of $45.00, for a total transaction of $294,435.00. Following the completion of the transaction, the insider directly owned 106,115 shares in the company, valued at approximately $4,775,175. The trade was a 5.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Adina Eckstein sold 5,000 shares of the business's stock in a transaction dated Monday, June 23rd. The stock was sold at an average price of $45.00, for a total value of $225,000.00. Following the transaction, the chief operating officer owned 189,653 shares of the company's stock, valued at $8,534,385. The trade was a 2.57% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 19,543 shares of company stock valued at $915,455 over the last 90 days. Corporate insiders own 14.70% of the company's stock.
Wall Street Analysts Forecast Growth
A number of research firms recently issued reports on LMND. Wall Street Zen raised Lemonade from a "sell" rating to a "hold" rating in a report on Saturday, August 9th. Piper Sandler reaffirmed a "neutral" rating and issued a $55.00 price target on shares of Lemonade in a report on Thursday, August 14th. Keefe, Bruyette & Woods reaffirmed an "underperform" rating and issued a $26.00 price target (up from $22.00) on shares of Lemonade in a report on Tuesday, July 1st. Cantor Fitzgerald raised Lemonade to a "strong-buy" rating in a report on Wednesday, August 13th. Finally, Morgan Stanley reissued an "underweight" rating on shares of Lemonade in a report on Monday, August 18th. One investment analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating, one has assigned a Hold rating and four have given a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Reduce" and an average price target of $40.43.
Read Our Latest Report on Lemonade
Lemonade Profile
(
Free Report)
Lemonade, Inc provides various insurance products through various channels in the United States, Europe, and the United Kingdom. Its insurance products include stolen or damaged property, and personal liability that protects its customers if they are responsible for an accident or damage to another person or their property.
Read More

Before you consider Lemonade, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lemonade wasn't on the list.
While Lemonade currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here

We are about to experience the greatest A.I. boom in stock market history...
Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.
That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.
- The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
- The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
- Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.
Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.
And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...
Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.